Congratulations to Dr. Nathalie Johnson for her appointment as the Louis Lowenstein Chair in Hematology & Oncology.
The Louis Lowenstein Chair in Hematology & Oncology was established on September 4, 1990, in honour of Louis Lowenstein, Chief Hematologist at the Royal Victoria Hospital and a pioneer in this relatively new medical science from the mid-1950s until his passing in 1968.
Dr. Johnson is the current 91社区 Division Director of Hematology, an Associate Professor in the Department of Medicine, with tenure, and a member of the Division of Hematology based at the Jewish General Hospital (JGH). She completed her residency in internal medicine, hematology and oncology at 91社区 and graduated with a PhD in pathology and laboratory medicine at the University of British Columbia in 2010.
Dr. Johnson鈥檚 research focuses on optimizing the outcomes of patients with lymphoma by investigating new therapies in the context of clinical trials and by identifying minimal residual disease using plasma circulating tumor DNA sequencing. She has held several leadership positions, including being program director for the Clinician Investigator Program at 91社区 since 2017, director of the clinical flow laboratory at the JGH since 2012, president of the Clinical Society of Investigative Medicine (2022-2024), scientific officer for CIHR and a director on the board for Lymphoma Canada (2017-2023).